Details for Patent: 6,294,195
✉ Email this page to a colleague
Summary for Patent: 6,294,195
Title: | Orally administrable opioid formulations having extended duration of effect |
Abstract: | Sustained release oral solid dosage forms of opioid analgesics are provided as multiparticulate systems which are bioavailable and which provide effective blood levels of the opioid analgesic for at least about 24 hours. A unit dose of the opioid analgesic contains a plurality of substrates including the opioid analgesic in sustained release form. The substrates have a diameter from about 0.1 mm to about 3 mm. |
Inventor(s): | Oshlack; Benjamin (New York, NY), Chasin; Mark (Manalapan, NJ) |
Assignee: | Purdue Pharma L.P. (Stamford, CT) |
Application Number: | 09/390,719 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,294,195 |
Patent Claim Types: see list of patent claims | Dosage form; |
Drugs Protected by US Patent 6,294,195
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,294,195
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 138566 | ⤷ Try a Trial | |||
Austria | 172376 | ⤷ Try a Trial | |||
Austria | 184786 | ⤷ Try a Trial | |||
Austria | 196079 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |